Literature DB >> 9764964

Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children.

B J Anderson1, N H Holford, G A Woollard, P L Chan.   

Abstract

AIMS: Paracetamol has a central action for both antipyresis and analgesia. Maximum temperature decrease and peak analgesia are reported at 1-2 h after peak plasma paracetamol concentration. We wished to determine the relationship between plasma and cerebrospinal fluid (CSF) pharmacokinetics in children.
METHODS: Concentration-time profiles in plasma and CSF after nasogastric paracetamol 40 mg kg(-1) were measured in nine children who had indwelling ventricular drains. Estimation of population pharmacokinetic parameters was made using both a standard two-stage population approach (MKMODEL) and a nonlinear mixed effect model (NONMEM). Results were standardized to a 70 kg person using an allometric power model.
RESULTS: Both approaches gave similar estimates. NONMEM parameter estimates were clearance 10.21 h(-1) (CV 47%), volume of distribution 67.11 (CV 58%) and absorption rate constant 0.77 h(-1) (CV 49%). Cerebrospinal fluid concentrations lagged behind those of plasma. The equilibration half time was 0.72 h (CV 117%). The CSF/plasma partition coefficient was 1.18 (CV 8%).
CONCLUSIONS: Higher concentrations in the CSF probably reflect the lower free water volume of plasma. The CSF equilibration half time suggests that CSF kinetics approximate more closely to the effect compartment than plasma, but further time is required for paracetamol to exert its effects. Effect site concentrations equilibrate slowly with plasma. Paracetamol should be given 1-2 h before anticipated pain or fever in children.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764964      PMCID: PMC1873683          DOI: 10.1046/j.1365-2125.1998.00780.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  41 in total

1.  Pharmacokinetics of paracetamol after cardiac surgery.

Authors:  C S Hopkins; S Underhill; P D Booker
Journal:  Arch Dis Child       Date:  1990-09       Impact factor: 3.791

2.  The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system.

Authors:  J B van Bree; A V Baljet; A van Geyt; A G de Boer; M Danhof; D D Breimer
Journal:  J Pharmacokinet Biopharm       Date:  1989-08

Review 3.  Antipyretics.

Authors:  C G Van Arman; D A Armstrong; D H Kim
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

Review 4.  Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients.

Authors:  B J Anderson; A D McKee; N H Holford
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

5.  The pharmacokinetics of propofol in children using three different data analysis approaches.

Authors:  B K Kataria; S A Ved; H F Nicodemus; G R Hoy; D Lea; M Y Dubois; J W Mandema; S L Shafer
Journal:  Anesthesiology       Date:  1994-01       Impact factor: 7.892

6.  Ibuprofen, acetaminophen, and placebo treatment of febrile children.

Authors:  P D Walson; G Galletta; N J Braden; L Alexander
Journal:  Clin Pharmacol Ther       Date:  1989-07       Impact factor: 6.875

7.  Altered gastric emptying in the head-injured patient: relationship to feeding intolerance.

Authors:  L Ott; B Young; R Phillips; C McClain; L Adams; R Dempsey; P Tibbs; U Y Ryo
Journal:  J Neurosurg       Date:  1991-05       Impact factor: 5.115

8.  Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures.

Authors:  A Van Esch; H A Van Steensel-Moll; E W Steyerberg; M Offringa; J D Habbema; G Derksen-Lubsen
Journal:  Arch Pediatr Adolesc Med       Date:  1995-06

9.  Pharmacokinetics of paracetamol in the neonate and infant after administration of propacetamol chlorhydrate.

Authors:  E Autret; J P Dutertre; M Breteau; A P Jonville; Y Furet; J Laugier
Journal:  Dev Pharmacol Ther       Date:  1993

10.  Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P.

Authors:  R Björkman; K M Hallman; J Hedner; T Hedner; M Henning
Journal:  Pain       Date:  1994-06       Impact factor: 6.961

View more
  20 in total

1.  A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children.

Authors:  B J Anderson; G A Woollard; N H Holford
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

2.  Cerebrospinal fluid pharmacokinetics of paracetamol after intravenous propacetamol in a former preterm infant.

Authors:  K Allegaert; R Verbesselt; H Devlieger; J de Hoon; D Tibboel
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

Review 3.  Neonatal exposure to drugs in breast milk.

Authors:  Patrick J McNamara; Maggie Abbassi
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

4.  Population Pharmacokinetic Modeling of Guanfacine in Pediatric Patients.

Authors:  William Knebel; Mary Corcoran; James Ermer; Marc R Gastonguay
Journal:  Clin Pharmacokinet       Date:  2015-08       Impact factor: 6.447

Review 5.  Population pharmacokinetic studies in pediatrics: issues in design and analysis.

Authors:  Bernd Meibohm; Stephanie Läer; John C Panetta; Jeffrey S Barrett
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 6.  Paracetamol: new vistas of an old drug.

Authors:  Alfio Bertolini; Anna Ferrari; Alessandra Ottani; Simona Guerzoni; Raffaella Tacchi; Sheila Leone
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

7.  Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers.

Authors:  M Valle; M J Barbanoj; A Donner; I Izquierdo; U Herranz; N Klein; H G Eichler; M Müller; M Brunner
Journal:  Eur J Clin Pharmacol       Date:  2005-02-12       Impact factor: 2.953

8.  Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.

Authors:  Philippe Cottagnoud; Fernando Acosta; Marianne Cottagnoud; Marc Pfister; Martin G Täuber
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

9.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

10.  Acetaminophen in cerebrospinal fluid in children.

Authors:  C D van der Marel; B J Anderson; M A L Pluim; T H R de Jong; A Gonzalez; D Tibboel
Journal:  Eur J Clin Pharmacol       Date:  2003-07-04       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.